KIRSTIN HERMANO: Open Payments
NPI 1588034938 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 31 payments from 13 companies in 2025. Trend: 2023 $538 · 2024 $759 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $470 |
| Abbott Laboratories | 2 | $231 |
| Novo Nordisk Inc | 6 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $153 |
| Kowa Pharmaceuticals America, Inc. | 3 | $137 |
| ABBVIE INC. | 3 | $56 |
| PFIZER INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Optinose US, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, Ozempic, Kerendia, ZORYVE, BREZTRI, UBRELVY, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
